Published 2 Oct 2014
Aspen Oss is pleased to confirm that the US Food and Drug Administration (FDA) has completed a successful inspection of the API manufacturing facilities in Oss, the Netherlands during the period of September 22nd until September 25th, 2014.
The inspection found the site to be compliant with the principles and guidelines of Good Manufacturing Practice (GMP) and no Form 483 observations were issued.
